OrbiMed

OrbiMed

OrbiMed

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will he
Founded
1989
Follow us
$100,000,000 Venture capital (Series C)
ChinaMoneyNetwork , DealStreetAsia

CAR-T Biotech Firm Gracell Completes $100 Million Round – China Money Network

MedCity News

Augmedix goes public through reverse merger

$45,000,000 Venture capital (Series D)
FinSMEs

TigerConnect Closes $45M Series D Funding

$85,000,000 Venture capital (Series C)
FinSMEs

Olema Oncology Raises $85M in Series C Financing

$64,000,000 Undisclosed
FinSMEs

Galecto Raises US$64M in Funding

$147,000,000 Venture capital (Series D)
FinSMEs

InventisBio Raises $147M in Series D Financing

$36,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Erasca Completes $36M Extension of Series B Financing

FinSMEs

NeuroPace Raises $67M in Funding

$98,000,000 Venture capital (Series C)
FinSMEs

Kinnate Biopharma Closes $98M Series C Financing

$44,000,000 Venture capital (Series C)
FinSMEs

ReViral Raises $44M in Series C Financing

Xconomy

FDA Rejects Tricida Chronic Kidney Disease Drug, More Data Needed

$106,000,000 Post-IPO equity
FinSMEs

Chinook Therapeutics Raises $106M in Funding

GeekWire

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

$48,000,000 Venture capital
WSJ Venture Capital

Aerin Medical Grabs $48 Million for Nasal Airway Treatments

$450,000,000
FinSMEs

Bayer to Buy KaNDy Therapeutics

$20,000,000 Seed fund
GeekWire

New biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI

FinSMEs

GentiBio Raises $20M in Seed Funding

Xconomy

GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology

$34,600,000 Venture capital (Series A)
FinSMEs

MBX Biosciences Closes $34.6M Series A Financing

$54,000,000 Venture capital (Series B)
Pulse 2.0 , FinSMEs

Olema Oncology Secures $54 Million To Advance Lead Program In Breast Cancer